Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Pharming Group N.V. - Filing #1859781

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
147,871,000 USD
155,241,000 USD
136,479,000 USD
Current assets
249,444,000 USD
263,212,000 USD
119,435,000 USD
Non-current liabilities
157,628,000 USD
158,169,000 USD
24,273,000 USD
Current liabilities
46,771,000 USD
76,849,000 USD
114,254,000 USD
Revenue
198,871,000 USD
212,174,000 USD
Profit (loss)
USD
USD
USD
USD
USD
USD
15,996,000 USD
15,996,000 USD
37,746,000 USD
37,746,000 USD
USD
USD
USD
USD
USD
USD
Other comprehensive income
2,283,000 USD
USD
270,000 USD
15,072,000 USD
USD
USD
17,085,000 USD
USD
14,956,000 USD
USD
USD
USD
USD
USD
14,956,000 USD
USD
Comprehensive income
2,283,000 USD
USD
270,000 USD
15,072,000 USD
USD
USD
1,089,000 USD
15,996,000 USD
52,702,000 USD
37,746,000 USD
USD
USD
USD
USD
14,956,000 USD
USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.